121 related articles for article (PubMed ID: 27125890)
21. [Achievement of therapeutic target in subjects on statin treatment in clinical practice. Results of the STAR (Statins Target Assessment in Real practice) study].
Degli Esposti L; Sangiorgi D; Arca M; Vigna GB; Budal S; Degli Esposti E
Monaldi Arch Chest Dis; 2011 Dec; 76(4):160-7. PubMed ID: 22567731
[TBL] [Abstract][Full Text] [Related]
22. Association between statin adherence and cholesterol level reduction from baseline in a veteran population.
Kazerooni R; Watanabe JH; Bounthavong M
Pharmacotherapy; 2013 Oct; 33(10):1044-52. PubMed ID: 23744794
[TBL] [Abstract][Full Text] [Related]
23. LDL-cholesterol trajectories and statin treatment in Finnish type 2 diabetes patients: a growth mixture model.
Inglin L; Lavikainen P; Jalkanen K; Laatikainen T
Sci Rep; 2021 Nov; 11(1):22603. PubMed ID: 34799657
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the prescription and utilization patterns of statins in an Italian local health unit during the period 1994-2003.
Deambrosis P; Saramin C; Terrazzani G; Scaldaferri L; Debetto P; Giusti P; Chinellato A
Eur J Clin Pharmacol; 2007 Feb; 63(2):197-203. PubMed ID: 17200832
[TBL] [Abstract][Full Text] [Related]
25. Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survival.
Leeper NJ; Ardehali R; deGoma EM; Heidenreich PA
Circulation; 2007 Aug; 116(6):613-8. PubMed ID: 17664373
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
27. Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke.
Valentino M; Al Danaf J; Panakos A; Ragupathi L; Duffy D; Whellan D
Am Heart J; 2016 Nov; 181():130-136. PubMed ID: 27823684
[TBL] [Abstract][Full Text] [Related]
28. LDL-C goal attainment in patients who remain on atorvastatin or switch to equivalent or non-equivalent doses of simvastatin: a retrospective matched cohort study in clinical practice.
Rublee DA; Burke JP
Postgrad Med; 2010 Mar; 122(2):16-24. PubMed ID: 20203452
[TBL] [Abstract][Full Text] [Related]
29. Cholesterol levels and statin use in patients with coronary heart disease treated in primary care settings.
O'Connor PJ; Gray RJ; Maciosek MV; Fillbrandt KM; DeFor TA; Alexander CM; Weiss TW; Teutsch SM
Prev Chronic Dis; 2005 Jul; 2(3):A05. PubMed ID: 15963307
[TBL] [Abstract][Full Text] [Related]
30. Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease.
van de Woestijne AP; van der Graaf Y; Westerink J; Nathoe HM; Visseren FL
Am J Cardiol; 2015 Feb; 115(4):441-6. PubMed ID: 25554536
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of two statin prescribing strategies with respect to adherence and cardiovascular outcomes: observational study.
Wei L; MacDonald TM; Watson AD; Murphy MJ
Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):385-92. PubMed ID: 16998946
[TBL] [Abstract][Full Text] [Related]
32. Patterns of statin use and cholesterol goal attainment in a high-risk cardiovascular population: A retrospective study of primary care electronic medical records.
García-Gil M; Blanch J; Comas-Cufí M; Daunis-i-Estadella J; Bolíbar B; Martí R; Ponjoan A; Alves-Cabratosa L; Ramos R
J Clin Lipidol; 2016; 10(1):134-42. PubMed ID: 26892130
[TBL] [Abstract][Full Text] [Related]
33. Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins.
Sakamoto K; Kawamura M; Kohro T; Omura M; Watanabe T; Ashidate K; Horiuchi T; Hara H; Sekine N; Chin R; Tsujino M; Hiyoshi T; Tagami M; Tanaka A; Mori Y; Inazawa T; Hirano T; Yamazaki T; Shiba T;
PLoS One; 2015; 10(9):e0138332. PubMed ID: 26398887
[TBL] [Abstract][Full Text] [Related]
34. Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.
Yang X; So WY; Ma RC; Ko GT; Kong AP; Zhao H; Luk AO; Lam CW; Ho CS; Tong PC; Chan JC
Diabetes Care; 2009 Oct; 32(10):1826-32. PubMed ID: 19592629
[TBL] [Abstract][Full Text] [Related]
35. Treatment Patterns, Statin Intolerance, and Subsequent Cardiovascular Events Among Japanese Patients With High Cardiovascular Risk Initiating Statin Therapy.
Nagar SP; Rane PP; Fox KM; Meyers J; Davis K; Beaubrun A; Inomata H; Qian Y; Kajinami K
Circ J; 2018 Mar; 82(4):1008-1016. PubMed ID: 29276211
[TBL] [Abstract][Full Text] [Related]
36. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.
Monson JP; Jönsson P; Koltowska-Häggström M; Kourides I
Clin Endocrinol (Oxf); 2007 Oct; 67(4):623-8. PubMed ID: 17581260
[TBL] [Abstract][Full Text] [Related]
37. Statin adherence and LDL cholesterol levels. Should we assess adherence prior to statin upgrade?
Vodonos A; Ostapenko I; Toledano R; Henkin Y; Zahger D; Wolak T; Sherf M; Novack V
Eur J Intern Med; 2015 May; 26(4):268-72. PubMed ID: 25770073
[TBL] [Abstract][Full Text] [Related]
38. Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education.
Wei MY; Ito MK; Cohen JD; Brinton EA; Jacobson TA
J Clin Lipidol; 2013; 7(5):472-83. PubMed ID: 24079289
[TBL] [Abstract][Full Text] [Related]
39. Analysis and comparison of statin prescription patterns and outcomes according to clinical department.
Kim HS; Kim H; Lee H; Park B; Park S; Lee SH; Cho JH; Song H; Kim JH; Yoon KH; Choi IY
J Clin Pharm Ther; 2016 Feb; 41(1):70-7. PubMed ID: 26791968
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of treat-to-target strategy for LDL-cholesterol control in type 2 diabetes: post-hoc analysis of data from the MIND.IT study.
Ardigò D; Vaccaro O; Cavalot F; Rivellese AA; Franzini L; Miccoli R; Patti L; Boemi M; Trovati M; Zavaroni I;
Eur J Prev Cardiol; 2014 Apr; 21(4):456-63. PubMed ID: 23147277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
